Skip to Content

Scientific portfolio

Scientific portfolio

Scientific portfolio

Contact us

Join us in revolutionizing oncology treatment and beyond: Investment and partnering opportunity.

contact@sortinapharma.com

Erik Dahlbergsgatan 11A
411 24 Gothenburg, Sweden

At Sortina, the overall goal is to create life-saving, world-class small molecule therapeutics targeting sortilin. By using the sortilin approach we aim to develop molecules characterized by superior efficacy and safety, providing novel tools for treatment of cancer, neurodegenerative diseases, and beyond

Address
Erik Dahlbergsgatan 11A
411 24 Gothenburg, Sweden

contact@sortinapharma.com